FDA Import Refusal AEK-6461474-4/11/1 — Eli Lilly & Co

Eli Lilly & Co — FEI 3009963246

The FDA refused shipment AEK-6461474-4/11/1 from Eli Lilly & Co (United States) on Oct 1, 2024. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Oct 1, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
61PCL74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
75